Elise Ngobi
Elise is the Director of International Growth at leading visual marketing platform Dash Hudson. Her expertise draws from years in the growth marketing world at firms like Raconteur and Storefront. Her current role brings global brands like Farfetch, Cult Beauty, and Condé Nast the tools they need to build meaningful relationships with their online audiences.
Colette Newberry
Co-founder Colette Newberry has a well-rounded commercial background in retail (combined 13 years in Walgreens Boots Alliance in trading, product development & brand roles), with entrepreneurial spirit - Colette having driven a 1m following millennial targeted start up into commercial success. The mix of Science and Beauty Junkie natures combine in Be for Beauty’s 2 co-founders to create an electric mix of creativity, spark and passion for innovation.
Mark Sproston
"EVERY MAN DESERVES TO BE FREE OF SHAVING IRRITATION"
That is the mission of Mark Sproston, Founder and CEO of The ShaveDoctor.
Mark has spent 2 decades working in and teaching the art of the 'Barber Shop Shave' to barbers all across the world and is now seen as a world leading shave expert and industry advisor.
Continued to be fascinated and frustrated by men’s reluctance to shave regularly because of shaving rash, razor burn and ingrown hairs, Mark created, with some leading dermatologists and chemists a professional shave and skin care range to match the shaving science to his shaving skill and free men from the irritation of shaving.
Our products have been expertly developed using more natural ingredients that contain no parabens or petro chemicals that will protect, soothe and treat all skin types no matter of age and ethnicity.
Today they are sold in many countries across the world with our aim to continue to develop innovative and high performing shave and skin care products for our customers to use and enjoy.
Kristy Macdonald
Alejandro Vicente
Vicente & Partners is a differentiated advisory boutique, based in NYC and London, exclusively focused on the Consumer Goods & Services sector.
V&P offers deep sector expertise gained at both Investment banks & Consumer Goods companies.
This unique blend of experience allows us to provide a differentiated service & perspective to our clients.
V&P advises clients on M&A, Capital Raise and Partnership/Licensing situations in a highly dedicated & discreet manner.
We facilitate senior connections across our network & create tailor-made solutions, with the mission to fuel our clients’ ambitions of growth & value creation.
V&P believes in giving back & helping others and does so by pledging a portion of its revenues from every transaction to charitable organizations in line with V&P's mission and values.
Alejandro Vicente has more than 25 years’ experience in the Consumer Goods & Services sector of which 17 years spent at JPMorgan where he was the Global Head of the Consumer Goods Investment Bank.
His first pet related transaction was almost 20 years ago when he advised Mars/Masterfoods in the acquisition of Royal Canin from PAI for Euro 1.5bn in 2001.
Since then, he has been involved in more than 40 transactions advising publicly quoted companies, private companies as well as private equity across various consumer goods sub-sectors.
David R. Boyko
David R. Boyko is Director, Global Business Development for Merck Animal Health (known as MSD Animal Health outside the United States and Canada), a part of Merck & Co., Inc., Kenilworth, NJ. In this role, David is responsible to identify, evaluate, negotiate and execute licensing and business development transactions for animal health products and services, including newly emerging animal diseases, biopharmaceuticals, vaccines, drug and vaccine delivery and new, digital technologies. Geographically, he focuses on opportunities for the North American business units.
Underpinning that role are more than twenty years of legal practice, with twenty of those years as a deal lawyer, business partner and counselor in the life sciences industry. His legal career includes extensive experience in corporate development and licensing activities for prescription, over-the-counter health and animal health products and technologies, as well as in the new area of digital health. He has advised executive and senior management levels on a broad range of legal issues, including M&A, regulatory, commercial, corporate governance and litigation, managed lawyers and controlled outside counsel annual budgets in excess of $2MM. David also has been Division Counsel for Healthcare Services & Solutions, Merck's business unit for innovative, non-drug healthcare solutions, a Senior Counsel in the Corporate Transactions Groups of both Merck and Schering-Plough, and an executive officer for Xenogen Corporation. In private practice, David was with the law firms of Wilson Sonsini Goodrich & Rosati and Fried, Frank, Harris, Shriver & Jacobson. He has a number of published articles on intellectual property and antitrust matters, and has chaired licensing panels at several annual meetings of the Association of Corporate Counsel.
David earned his J.D. degree from the University of California Los Angeles, his M.A. degree in International Relations from the University of Southern California and his B.S. degree in Mechanical Engineering from Cornell University. David is also a veteran, having served eight years of active duty as a U.S. Air Force officer.